COMMUNIQUÉS West-GlobeNewswire
-
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/11/2026 -
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/11/2026 -
Chemed Corporation Declares Quarterly Dividend of 70 Cents
06/11/2026 -
HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer
06/11/2026 -
SOTIO Presents Initial Data from VICTORIA-01 Phase 1 Clinical Study of Immunocytokine SOT201 at SITC Annual Meeting
06/11/2026 -
Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting
06/11/2026 -
Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio
06/11/2026 -
Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026
06/11/2026 -
Azalea Therapeutics Presents New Preclinical Data at SITC 2026 Highlighting Durable Anti-Tumor Activity and Modular Capabilities of its In Vivo CAR T Cell Platform
06/11/2026 -
ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London
06/11/2026 -
CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
06/11/2026 -
Quoin Pharmaceuticals’ Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome
06/11/2026 -
BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing Approval Application
06/11/2026 -
OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook
06/11/2026 -
Notification of managers’ transactions
06/11/2026 -
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
06/11/2026 -
MIMEDX to Participate in Upcoming Investor Conferences
06/11/2026 -
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026 -
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
06/11/2026
Pages